The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bagheri‐Yarmand, R., Talukder, A. H., Wang, R., Vadlamudi, R. K., & Kumar, R. (2004) · Development · doi:10.1242/dev.01213 · Cited by 97
RetractedStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,639
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Proteomic analysis of post-translational modifications
Mann, M., & Jensen, O. N. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-255 · Cited by 2,134
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A., & Yao, T.-P. (2003) · Cell · doi:10.1016/s0092-8674(03)00939-5 · Cited by 1,524
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
The Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
The structure of DNA in the nucleosome core
Richmond, T. J., & Davey, C. A. (2003) · Nature · doi:10.1038/nature01595 · Cited by 1,286
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
Shaping the nuclear action of NF-κB
Chen, L.-F., & Greene, W. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1368 · Cited by 1,221
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor
Kovacs, J. J., Murphy, P. J. M., Gaillard, S., Zhao, X., Wu, J.-T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., & Yao, T.-P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.021 · Cited by 1,153 · cited 1×
“HSP90 hyper-acetylation in HDAC6-deficient cells leads to the loss of chaperone activit”
BackgroundCellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103
Global histone modification patterns predict risk of prostate cancer recurrence
Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,092
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Kelly, W. K., O'Connor, O. A., Krug, L. M., Chiao, J. H., Heaney, M., Curley, T., MacGregore-Cortelli, B., Tong, W., Secrist, J. P., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.167 · Cited by 905
Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis
Vega, R. B., Matsuda, K., Oh, J., Barbosa, A. C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J. M., Richardson, J. A., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.024 · Cited by 804
Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue
Yuan, Z.-L., Guan, Y.-J., Chatterjee, D., & Chin, Y. E. (2005) · Science · doi:10.1126/science.1105166 · Cited by 790
Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787
Self-citationEssential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2672 · Cited by 760
Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500186200 · Cited by 755
Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754
Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710 · cited 1×
“From the structure of HDAC8 or HDLP (a HDAC-like protein isolated from Aquifex aeolicus ), and the structure of these enzymes in complex with a small number of HDACi, a few key points have emerged about the active site that support a pharmacophore model for HDAC inhibitio”
BackgroundClass II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664
(1996) · Europe PMC (PubMed Central) · Cited by 659
Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
Iyer, N. G., Özdag, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 638
Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3
Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J., & Wong, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4342 · Cited by 629
Kelly, W. K., Richon, V. M., O’Connor, O. A., Curley, T., MacGregor‐Cortelli, B., Tong, W. P., Klang, M. G., Schwartz, L. B., Richardson, S., Rosa, E., et al. (2003) · PubMed · Cited by 624
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2005) · Nature Medicine · doi:10.1038/nm1161 · Cited by 610
Apoptotic and autophagic cell death induced by histone deacetylase inhibitors
Shao, Y., Gao, Z., Marks, P. A., & Jiang, X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408345102 · Cited by 605
Hideshima, T., Bradner, J. E., Wong, J., Chauhan, D., Richardson, P., Schreiber, S. L., & Anderson, K. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503221102 · Cited by 593
Acetylation of the C Terminus of Ku70 by CBP and PCAF Controls Bax-Mediated Apoptosis
Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B., Imahiyerobo, T. A., Miller, C., Frye, R., Ploegh, H., Kessler, B. M., & Sinclair, D. A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00094-2 · Cited by 578
Therapeutic implications of cancer stem cells
Al-Hajj, M., Becker, M. W., Wicha, M., Weissman, I., & Clarke, M. F. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.007 · Cited by 566
Gui, C.-Y., Ngo, L., Xu, W. S., Richon, V. M., & Marks, P. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307708100 · Cited by 550
Peart, M. J., Smyth, G. K., van Laar, R. K., Bowtell, D. D., Richon, V. M., Marks, P. A., Holloway, A. J., & Johnstone, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500369102 · Cited by 539
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
Archer, S. Y., Meng, S., Shei, A., & Hodin, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6791 · Cited by 535
Mitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Shringarpure, R., Hideshima, T., Akiyama, M., Chauhan, D., Munshi, N., Gu, X., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536759100 · Cited by 531
Histone Deacetylase Inhibitors
Miller, T. A., Witter, D. J., & Belvedere, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0303094 · Cited by 530
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.-P., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 525
(2003) · PubMed · Cited by 519
Insinga, A., Monestiroli, S., Ronzoni, S., Gelmetti, V., Marchesi, F., Viale, A., Altucci, L., Nervi, C., Minucci, S., & Pelicci, P. G. (2005) · Nature Medicine · doi:10.1038/nm1160 · Cited by 516
Self-citationUngerstedt, J. S., Sowa, Y., Xu, W.-S., Shao, Y., Dokmanovic, M., Perez, G., Ngo, L., Holmgren, A., Jiang, X., & Marks, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408732102 · Cited by 503
Sandor, V. A., Bakke, S., Robey, R. W., Kang, M. H., Blagosklonny, M. V., Bender, J., Brooks, R. A., Piekarz, R., Tucker, E. E., Figg, W. D., et al. (2002) · PubMed · Cited by 502
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K., & Benz, C. C. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095825 · Cited by 494
Lund, A. H., & van Lohuizen, M. (2004) · Genes & Development · doi:10.1101/gad.1232504 · Cited by 489
A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness
Guenther, M. G., Lane, W. S., Fischle, W., Verdin, E., Lazar, M. A., & Shiekhattar, R. (2000) · Genes & Development · doi:10.1101/gad.14.9.1048 · Cited by 489
(2003) · PubMed · Cited by 465
Histone deacetylase inhibitors in cancer therapy
Johnstone, R. W., & Licht, J. D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00165-x · Cited by 449
Piekarz, R. L., Robey, R., Sandor, V., Bakke, S., Wilson, W. H., Dahmoush, L., Kingma, D. M., Turner, M. L., Altemus, R., & Bates, S. E. (2001) · Blood · doi:10.1182/blood.v98.9.2865 · Cited by 445
A PMLRAR α transgene initiates murine acute promyelocytic leukemia
Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2551 · Cited by 434
Self-citationRyan, Q. C., Headlee, D., Acharya, M., Sparreboom, A., Trepel, J. B., Ye, J., Figg, W. D., Hwang, K., Chung, E. J., Murgo, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.188 · Cited by 411
Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-05-1693 · Cited by 398
Acetylation inactivates the transcriptional repressor BCL6
Bereshchenko, O. R., Gu, W., & Dalla-Favera, R. (2002) · Nature Genetics · doi:10.1038/ng1018 · Cited by 394
Control of Smad7 Stability by Competition between Acetylation and Ubiquitination
Grönroos, E., Hellman, U., Heldin, C.-H., & Ericsson, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00639-1 · Cited by 383
Grisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., & Ley, T. J. (1997) · Blood · doi:10.1182/blood.v89.2.376 · Cited by 352
Self-citationMunshi, A., Kurland, J. F., Nishikawa, T., Tanaka, T., Hobbs, M. L., Tucker, S. L., Ismail, S., Stevens, C., & Meyn, R. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2088 · Cited by 345
Seigneurin-Berny, D., Verdel, A., Curtet, S., Lemercier, C., Garin, J., Rousseaux, S., & Khochbin, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8035-8044.2001 · Cited by 335
Humphrey, G. W., Wang, Y., Russanova, V. R., Hirai, T., Qin, J., Nakatani, Y., & Howard, B. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007372200 · Cited by 331
Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., & Lazar, M. A. (2000) · Genes & Development · doi:10.1101/gad.14.1.45 · Cited by 325
Histone deacetylation in epigenetics: An attractive target for anticancer therapy
Mai, A., Massa, S., Rotili, D., Cerbara, I., Valente, S., Pezzi, R., Simeoni, S., & Ragno, R. (2005) · Medicinal Research Reviews · doi:10.1002/med.20024 · Cited by 319
He, L.-Z., Tolentino, T., Grayson, P., Zhong, S., Warrell, R. P., Rifkind, R. A., Marks, P. A., Richon, V. M., & Pandolfi, P. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11537 · Cited by 303
Caron, C., Boyault, C., & Khochbin, S. (2005) · BioEssays · doi:10.1002/bies.20210 · Cited by 291
Oligomerization of RAR and AML1 Transcription Factors as a Novel Mechanism of Oncogenic Activation
Minucci, S., Maccarana, M., Cioce, M., De Luca, P., Gelmetti, V., Segalla, S., Di Croce, L., Giavara, S., Matteucci, C., Gobbi, A., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80321-4 · Cited by 285
Self-citationWang, R., Cherukuri, P., & Luo, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413930200 · Cited by 275
Nakata, S., Yoshida, T., Horinaka, M., Shiraishi, T., Wakada, M., & Sakai, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207830 · Cited by 271
Reading signals on the nucleosome with a new nomenclature for modified histones
Turner, B. M. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0205-110 · Cited by 258
Qiu, L., Burgess, A., Fairlie, D. P., Leonard, H., Parsons, P. G., & Gabrielli, B. G. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.6.2069 · Cited by 249
Lin, R. J., & Evans, R. M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80322-6 · Cited by 232
Jin, Y.-H., Jeon, E.-J., Li, Q.-L., Lee, Y. H., Choi, J.-K., Kim, W.-J., Lee, K.-Y., & Bae, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313120200 · Cited by 211
Camphausen, K., Burgan, W., Cerra, M., Oswald, K. A., Trepel, J. B., Lee, M.-J., & Tofilon, P. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2630 · Cited by 209
Coordination of a Transcriptional Switch by HMGI(Y) Acetylation
Munshi, N., Agalioti, T., Lomvardas, S., Merika, M., Chen, G., & Thanos, D. (2001) · Science · doi:10.1126/science.293.5532.1133 · Cited by 206
Coactivator-Dependent Acetylation Stabilizes Members of the SREBP Family of Transcription Factors
Giandomenico, V., Simonsson, M., Grünroos, E., & Ericsson, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2587-2599.2003 · Cited by 205
Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A.
Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Saunthararajah, Y., & Hoffman, R. (2004) · Blood · doi:10.1182/blood-2003-07-2431 · Cited by 195
Piekarz, R. L., Robey, R. W., Zhan, Z., Kayastha, G., Sayah, A., Abdeldaim, A. H., Torrico, S., & Bates, S. E. (2004) · Blood · doi:10.1182/blood-2003-09-3068 · Cited by 186
HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma
Singh, T. R., Shankar, S., & Srivastava, R. K. (2005) · Oncogene · doi:10.1038/sj.onc.1208585 · Cited by 177
Acetylation of importin-α nuclear import factors by CBP/p300
Bannister, A. J., Miska, E. A., Görlich, D., & Kouzarides, T. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00445-0 · Cited by 176
Emerging roles of MTA family members in human cancers
KUMAR, R. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.005 · Cited by 176
Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors
Subramanian, C., Opipari, A. W., Bian, X., Castle, V. P., & Kwok, R. P. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408351102 · Cited by 172
Establishment of transcriptional competence in early and late S phase
Zhang, J., Xu, F., Hashimshony, T., Keshet, I., & Cedar, H. (2002) · Nature · doi:10.1038/nature01150 · Cited by 171
Leipe, D. D., & Landsman, D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.18.3693 · Cited by 168
SUMO and transcriptional regulation
Girdwood, D. W. H., Tatham, M. H., & Hay, R. T. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.001 · Cited by 164
Minucci, S., Nervi, C., Coco, F. L., & Pelicci, P. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204336 · Cited by 163
Self-citationHasan, S., Stucki, M., Hassa, P. O., Imhof, R., Gehrig, P., Hunziker, P., Hübscher, U., & Hottiger, M. O. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00272-6 · Cited by 162
Gore, S. D., Weng, L.-J., Figg, W. D., Zhai, S., Donehower, R. C., Dover, G. H., Grever, M. R., Griffin, C. A., Grochow, L. B., Hawkins, A. L., et al. (2002) · PubMed · Cited by 151
Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints
Warrener, R., Beamish, H., Burgess, A., Waterhouse, N. J., Giles, N., Fairlie, D. P., & Gabrielli, B. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-1003fje · Cited by 149
Park, J., Jung, Y., Kim, T. Y., Kim, S. G., Jong, H.-S., Lee, S. E., Kim, D.-K., Lee, J., Kim, N. K., Kim, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0709 · Cited by 143
Complicated Tails: Histone Modifications and the DNA Damage Response
Vidanes, G. M., Bonilla, C. Y., & Toczyski, D. P. (2005) · Cell · doi:10.1016/j.cell.2005.06.013 · Cited by 141
Yao, Y., & Yang, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302955200 · Cited by 134
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
Insinga, A., Monestiroli, S., Ronzoni, S., Carbone, R., Pearson, M. A., Pruneri, G., Viale, G., Appella, E., Pelicci, P. G., & Minucci, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600109 · Cited by 130
Self-citationChávez-Blanco, A. D., Segura-Pacheco, B. A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Cetina, L., Candelaria, M., de León, D. F. C., González‐Fierro, A., García‐López, P., Zambrano, P., et al. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-22 · Cited by 129
Subtype Selective Substrates for Histone Deacetylases
Heltweg, B., Dequiedt, F., Marshall, B. L., Brauch, C., Yoshida, M., Nishino, N., Verdin, E. M., & Jung, M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0497592 · Cited by 125
Patnaik, A., Rowinsky, E. K., Villalona, M. A., Hammond, L. A., Britten, C. D., Siu, L. L., Goetz, A. D., Felton, S., Burton, S., Valone, F. H., et al. (2002) · PubMed · Cited by 124
Acetylation Regulates the DNA End-Trimming Activity of DNA Polymerase β
Hasan, S., El‐Andaloussi, N., Hardeland, U., Hassa, P. O., Bürki, C., Imhof, R., Schär, P., & Hottiger, M. O. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00745-1 · Cited by 116
Molecular genetics of acute promyelocytic leukemia
Lin, R. J., Egan, D. A., & Evans, R. M. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01710-2 · Cited by 112
Retinoid receptors in health and disease: co-regulators and the chromatin connection
Minucci, S., & Pelicci, P. G. (1999) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1999.0303 · Cited by 110
Self-citationBandyopadhyay, D., Mishra, A., & Medrano, E. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3897 · Cited by 110
Toh, Y., Ohga, T., Endo, K., Adachi, E., Kusumoto, H., Haraguchi, M., Okamura, T., & Nicolson, G. L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20154 · Cited by 109
Bilton, R. L., Mazure, N. M., Trottier, E., Hattab, M., Déry, M.-A. C., Richard, D. E., Pouysségur, J., & Brahimi-Horn, M. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504482200 · Cited by 108
Watanabe, K., Okamoto, K., & Yonehara, S. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401507 · Cited by 102
Histone deacetylase inhibitors in clinical development
Rosato, R. R., & Grant, S. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.1.21 · Cited by 101
Pilatrino, C., Cilloni, D., Messa, E., Morotti, A., Giugliano, E., Pautasso, M., Familiari, U., Cappia, S., Pelicci, P. G., Lo‐Coco, F., et al. (2005) · Cancer · doi:10.1002/cncr.21132 · Cited by 100
Self-citationMultiple N-CoR Complexes Contain Distinct Histone Deacetylases
Jones, P. L., Sachs, L. M., Rouse, N., Wade, P. A., & Shi, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000879200 · Cited by 100
Caillaud, A., Prakash, A., Smith, E., Masumi, A., Hovanessian, A. G., Levy, D. E., & Marié, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207484200 · Cited by 89
Interaction of Histone Acetylases and Deacetylases In Vivo
Yamagoe, S., Kanno, T., Kanno, Y., Sasaki, S., Siegel, R. M., Lenardo, M. J., Humphrey, G. W., Wang, Y., Nakatani, Y., Howard, B. H., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1025-1033.2003 · Cited by 88
Raffoux, E., Chaı̈bi, P., Dombret, H., & Degos, L. (2005) · PubMed · Cited by 87
Siddiqui, H., Solomon, D. A., Gunawardena, R. W., Wang, Y., & Knudsen, E. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7719-7731.2003 · Cited by 85
Rahmani, M., Reese, E., Dai, Y., Bauer, C., Kramer, L. B., Huang, M., Jove, R., Dent, P., & Grant, S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007831 · Cited by 82
Varshochi, R., Halim, F., Sunters, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408063200 · Cited by 73
Xiao, J. J., Huang, Y. S., Dai, Z., Sadée, W., Chen, J., Liu, S., Marcucci, G., Byrd, J. C., Covey, J. M., Wright, J., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083956 · Cited by 67
New method to detect histone acetylation levels by flow cytometry
Ronzoni, S., Faretta, M., Ballarini, M., Pelicci, P. G., & Minucci, S. (2005) · Cytometry Part A · doi:10.1002/cyto.a.20151 · Cited by 66
Self-citationMai, A., Massa, S., Pezzi, R., Rotili, D., Loidl, P., & Brosch, G. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034167p · Cited by 60
The activities of eukaryotic replication origins in chromatin
Weinreich, M., DeBeer, M. A. P., & Fox, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.11.015 · Cited by 59
Inoue, H., Shiraki, K., Ohmori, S., Sakai, T., Deguchi, M., Yamanaka, T., Okano, H., & Nakano, T. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.5.521 · Cited by 54
Histone metabolic pathways and chromatin assembly factors as proliferation markers
Polo, S. E., & Almouzni, G. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.024 · Cited by 52
Eckner, R., Arany, Z. P., Ewen, M. E., Sellers, W. R., & Livingston, D. M. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.012 · Cited by 49
Rausa, F. M., Hughes, D. E., & Costa, R. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407472200 · Cited by 45
Analysis of p53 gene mutations in acute myeloid leukemia
Trecca, D., Longo, L., Biondi, A., Cro, L., Calori, R., Grignani, F., Maiolo, A. T., Pelicci, P. G., & Neri, A. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830460409 · Cited by 35
Self-citationAltered epigenetic signals in human disease
Croce, L. D., Buschbeck, M., Gutiérrez, A., Joval, I., Morey, L., Villa, R., & Minucci, S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.9.1103 · Cited by 19
Self-citationHistone Deacetylase Inhibitors: Assays to Assess Effectiveness In Vitro and In Vivo
Richon, V. M., Zhou, X., Secrist, J. P., Cordon‐Cardo, C., Kelly, W. K., Drobnjak, M., & Marks, P. A. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)76013-3 · Cited by 17
Qiang, L., Xiao, H., Campos, E. I., Ho, V., & Li, G. (2005) · Journal of Immunoassay and Immunochemistry · doi:10.1081/ias-200041153 · Cited by 16
Cited by
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Metadata
- Authors
- Minucci, S., & Pelicci, P. G.
- Venue
- Nature Reviews Cancer
- Published
- 2006-01-01
- Volume
- 6
- Issue
- 1
- Pages
- 38-51
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2099803844
- Cited by
- 2,200
- References
- 137
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.